Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature

BACKGROUND: Gastrointestinal perforation is known as a serious adverse event, but, for breast cancer, there are very few reports of gastrointestinal perforation. This report highlights gastrointestinal perforation caused by bevacizumab for breast cancer, which is of special interest because gastroin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Yusuke, Hirahara, Noriyuki, Kaji, Syunsuke, Taniura, Takahito, Hyakudomi, Ryoji, Yamamoto, Tetsu, Tajima, Yoshitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870367/
https://www.ncbi.nlm.nih.gov/pubmed/29580267
http://dx.doi.org/10.1186/s13256-018-1619-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870367/
https://www.ncbi.nlm.nih.gov/pubmed/29580267
http://dx.doi.org/10.1186/s13256-018-1619-x

Ejemplares similares